← Back to Search

Behavioural Intervention

Geriatric Assessment for Cancer in Seniors with Frailty or Cognitive Impairment

N/A

Waitlist Available

Led By Richard Spence, MD, FRCSC

Research Sponsored by Nova Scotia Health Authority

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients must have a pathologically confirmed diagnosis of bronchopulmonary, oropharyngeal, orthopaedic, gynaecological, breast or gastrointestinal cancer surgery

Patients must be screened by the CFS to have: 4a. Mild or greater frailty (CFS equal or greater than 5) due to cognitive impairment. 4b. Moderate or greater frailty (CFS equal or greater than 6) due to medical/physical conditions

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 6 months postoperatively

Awards & highlights

Study Summary

This trial is testing if pre-surgery geriatric assessment can help seniors aged 75+ stay at home longer after cancer surgery at QEII.

Who is the study for?

This trial is for patients aged 75 or older who are scheduled for elective cancer surgery and have been identified as severely frail or cognitively impaired. They must consent to the surgery, not live in long-term care before their diagnosis, and cannot be urgent/emergent cases.Check my eligibility

What is being tested?

The study compares standard preoperative care with a specialized geriatric assessment at the PATH clinic for elderly patients facing cancer surgery. The main goal is to see if this approach helps them spend more time at home after six months post-surgery.See study design

What are the potential side effects?

Since this trial involves assessments rather than medications, there are no direct side effects from drugs. However, changes in care based on the geriatric assessment could potentially lead to different health outcomes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a confirmed diagnosis of cancer in the lung, throat, bone, reproductive organs, breast, or digestive system.

Select...

I am considered frail due to cognitive issues or physical health conditions.

Select...

I am scheduled for surgery aimed at curing or relieving symptoms of my condition.

Select...

I am 75 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 6 months postoperatively

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 6 months postoperatively

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 6 months postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Preoperative factors associated with decreased proportion of time spent at home at 6 months.

Time spent at home 6 months following cancer surgery.

Secondary outcome measures

Decision regret scores.

Number of participants experiencing death or development of persistent significant new disability.

Number of participants requiring home care utilization

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PATH geriatric careExperimental Treatment1 Intervention

Pre-operative assessment through the PATH clinic

Group II: Standard of careActive Control1 Intervention

Patients will undergo the usual preoperative assessment from preoperative clinic which includes standard general internal medicine and anesthesia assessment.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor

258 Previous Clinical Trials

83,704 Total Patients Enrolled

2 Trials studying Frailty

148 Patients Enrolled for Frailty

Richard Spence, MD, FRCSCPrincipal InvestigatorQueen Elizabeth II Health Sciences Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment still need participants?

"According to clinicaltrials.gov, this medical trial has ceased patient enrollment as of August 31st 2023. It was first posted on September 1st 2023 and is not seeking participants at present; however there are 843 other trials active that are recruiting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.

Richard Spence 2023. "PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06022666.